Clinical evaluation of the new quick cortisol measurement kit (QCA) at adrenal vein sampling in patients with primary aldosteronism

Phase 3

• Conditions: Primary aldosteronism

• Registration Number: JPRN-UMIN000037157
• Lead Sponsor: Kanazawa University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-06-25
• Study Completion: 2022-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Not provided

Exclusion Criteria

1) The PA patients who do not hope for surgery 2) The patients who are taking spcific drugs (including the steroid) which affect a plasma aldosterone concentration and a plasma cortisol concentration 3) the patients with allergy for a natural rubber, cosyntropin and the iodocontrast media 4) The patients with unstable angina 5) The patients with the serious hepatic disorder (AST(GOT) or ALT (GPT) more than 100IU/L) 6) The patients with the pregnant or pregnant likelihood 7) The patients who are treated with malignant disorder except for the adrenal cancer 8) The patients with severe renal dysfunction (eGFR <20mL/min/1.73m2) 9) The patients who participated in other clinical trials within three months before AVS 10) The patients who were judged to be inadequate as study patients

Study & Design

• Study Type: Observational
• Study Design: Not specified